{"id":"crinone","rwe":[],"tags":[],"trials":[],"_chembl":{"chemblId":"CHEMBL103","moleculeType":"Small molecule","molecularWeight":"314.47"},"aliases":[],"patents":[],"pricing":[{"market":"United States","source":"CMS National Average Drug Acquisition Cost (NADAC)","asOfDate":"2024-04-17","unitCost":"$25.2990/GM","priceType":"NADAC","sourceUrl":"https://data.medicaid.gov/dataset/4j6z-xnwq","annualCost":"$9,234","description":"CRINONE 8% GEL","retrievedDate":"2026-04-07"}],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=Crinone","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:19:47.106751+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:19:52.813437+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=Crinone","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:19:53.245613+00:00"},"mechanism.target_chembl":{"url":"","method":"api_direct","source":"ChEMBL mechanism: Progesterone receptor agonist","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:19:54.270970+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL103/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:19:53.939898+00:00"}},"offLabel":[],"timeline":[],"_dailymed":{"setId":"75e97aa1-daa4-45f9-b2e2-1a371302914e","title":"CRINONE (PROGESTERONE) GEL [ALLERGAN, INC.]"},"ecosystem":[],"_scrapedAt":"2026-03-28T00:31:25.820Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"references":[],"_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:19:55.556953+00:00","fieldsConflicting":0,"overallConfidence":0.95},"biosimilars":[],"competitors":[],"dataSources":[{"url":"https://data.medicaid.gov/dataset/4j6z-xnwq","name":"CMS National Average Drug Acquisition Cost (NADAC)","fields":["pricing"],"retrievedDate":"2026-04-07"}],"labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT05954962","phase":"PHASE4","title":"Efficacy of Micronized Natural Progesterone vs GnRH Antagonist in the Prevention of LH Peak During Ovarian Stimulation.","status":"COMPLETED","sponsor":"Instituto Bernabeu","startDate":"2023-12-23","conditions":"IVF","enrollment":150},{"nctId":"NCT07496294","phase":"NA","title":"Comparison of Oral Dydrogesterone and Vaginal Progesterone in Menopausal Hormone Therapy","status":"NOT_YET_RECRUITING","sponsor":"Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital","startDate":"2026-04","conditions":"Menopausal Women, Menopausal Symptom Relief, Hormone Therapy","enrollment":200},{"nctId":"NCT06851754","phase":"PHASE3","title":"Hormone Replacement Therapy in Adolescents With Premature Ovarian Insufficiency","status":"RECRUITING","sponsor":"Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)","startDate":"2025-07-17","conditions":"Premature Ovarian Insufficiency","enrollment":185},{"nctId":"NCT04806919","phase":"PHASE3","title":"Luteal Support in Artificial Vitrified/Warmed Cycles With Low Progesterone","status":"COMPLETED","sponsor":"University Hospital, Ghent","startDate":"2021-04-02","conditions":"IVF, Embryo Loss, Luteal Phase Defect","enrollment":87},{"nctId":"NCT04983173","phase":"PHASE4","title":"INTEnsity of ovariaN Stimulation and Embryo Quality","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2021-11-23","conditions":"Infertility","enrollment":110},{"nctId":"NCT06239376","phase":"NA","title":"Artificial Cycle With or Without GnRH Agonist Pre-treatment for Frozen Embryo Transfer in Adenomyosis Patients","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-02-19","conditions":"Adenomyosis, IVF, Frozen Embryo Transfer","enrollment":222},{"nctId":"NCT07136922","phase":"PHASE1","title":"First in Human Safety and Ease of Use Assessment of 400mg Progesterone Callavid in Women With Luteal Phase Insufficiency","status":"NOT_YET_RECRUITING","sponsor":"Calla Lily Clinical Care Ltd","startDate":"2026-04","conditions":"Luteal Phase Insuffiency, Progesterone Delivery","enrollment":20},{"nctId":"NCT07358468","phase":"","title":"Impact Of FET Preparation Protocol On Endometrial Peristalsis: A Prospective Cohort Study","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2026-02-22","conditions":"Infertility, Endometrial Peristalsis, Uterine Contraction","enrollment":356},{"nctId":"NCT07466199","phase":"PHASE4","title":"Exogenous Progesterone as Ovulation Trigger","status":"NOT_YET_RECRUITING","sponsor":"Instituto Valenciano de Infertilidade de Lisboa","startDate":"2026-04","conditions":"Ovulation, Ovarian Function, Assisted Reproductive Treatments","enrollment":10},{"nctId":"NCT02518594","phase":"PHASE3","title":"A Trial of Pessary and Progesterone for Preterm Prevention in Twin Gestation With a Short Cervix","status":"COMPLETED","sponsor":"The George Washington University Biostatistics Center","startDate":"2015-11-13","conditions":"Short Cervical Length","enrollment":1311},{"nctId":"NCT07461909","phase":"","title":"Comparison of Two Vaginal Progesterone Forms in Frozen Embryo Transfer","status":"RECRUITING","sponsor":"Instituto Valenciano de Infertilidade de Lisboa","startDate":"2024-11-08","conditions":"Frozen Embryo Transfer (FET), Infertility, Artificial Cycle","enrollment":400},{"nctId":"NCT04872660","phase":"PHASE4","title":"Efficacy and Safety of Gushen Antai Pill on Ongoing Pregnancy Rate in Women With Normal Ovarian Reserve Undergoing IVF-ET","status":"RECRUITING","sponsor":"Shandong University of Traditional Chinese Medicine","startDate":"2021-06-15","conditions":"Infertility, Female","enrollment":800},{"nctId":"NCT07436793","phase":"PHASE2","title":"Progestins for the Treatment of Endometrial Cancer or Precancers of the Uterus Before Surgery, The Pro-Window Trial","status":"NOT_YET_RECRUITING","sponsor":"New Mexico Cancer Research Alliance","startDate":"2026-03-01","conditions":"Endometrial Endometrioid Adenocarcinoma, Endometrial Hyperplasia","enrollment":140},{"nctId":"NCT02913495","phase":"PHASE4","title":"Vaginal Versus Intramuscular Progesterone for the Prevention of Recurrent Preterm Birth","status":"COMPLETED","sponsor":"Thomas Jefferson University","startDate":"2016-09","conditions":"Premature Birth","enrollment":210},{"nctId":"NCT06307184","phase":"","title":"Assessing the Convenience of Natural Proliferative Phase Frozen Embryo Transfer","status":"RECRUITING","sponsor":"Instituto Valenciano de Infertilidade de Lisboa","startDate":"2024-02-23","conditions":"Frozen Embryo Transfer","enrollment":530},{"nctId":"NCT07372495","phase":"NA","title":"Cerclage Plus Progesterone vs Progesterone Alone in Twin Short Cervix","status":"NOT_YET_RECRUITING","sponsor":"National Hospital of Obstetrics and Gynecology","startDate":"2026-03-01","conditions":"Preterm","enrollment":260},{"nctId":"NCT04499131","phase":"PHASE4","title":"Impact of Different Doses and Routes of Exogenous Progesterone Administration on Endometrial Receptivity Parameters","status":"COMPLETED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2021-12-09","conditions":"Infertility, Female, ENDOMETRIAL RECEPTIVITY","enrollment":109},{"nctId":"NCT07378241","phase":"","title":"Effects of Patients' Hormone Levels on Sedoanalgesia","status":"NOT_YET_RECRUITING","sponsor":"Izmir City Hospital","startDate":"2026-01-30","conditions":"Consumption of Anaesthetic Agents, Sedoanalgesia","enrollment":100},{"nctId":"NCT04549116","phase":"PHASE3","title":"Subcutaneous Progesterone in Frozen- Thawed Single Euploid Blastocyst Transfer.","status":"ACTIVE_NOT_RECRUITING","sponsor":"IBSA Institut Biochimique SA","startDate":"2022-10-12","conditions":"Infertility","enrollment":680},{"nctId":"NCT06497894","phase":"PHASE4","title":"No More Sleepless Nights in Perimenopause","status":"RECRUITING","sponsor":"Insel Gruppe AG, University Hospital Bern","startDate":"2026-01-01","conditions":"Insomnia, Menopause","enrollment":54},{"nctId":"NCT02633878","phase":"PHASE3","title":"Chinese Herbal Medicine (New \"Shoutai Wan\") and/or Oral Progesterone Intervention Trial for Threatened Miscarriage","status":"COMPLETED","sponsor":"Heilongjiang University of Chinese Medicine","startDate":"2017-10-20","conditions":"Threatened Miscarriage","enrollment":1656},{"nctId":"NCT07010146","phase":"PHASE2","title":"Role of Estrogen on Skeletal Outcomes in FHA","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2025-07-01","conditions":"Bone Strength, Bone Density, FHA (Functional Hypothalamic Amenorrhea)","enrollment":150},{"nctId":"NCT05091866","phase":"EARLY_PHASE1","title":"Natural Progesterone for the Treatment of Recurrent Glioblastoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2022-04-11","conditions":"Gliosarcoma, Recurrent Glioblastoma","enrollment":4},{"nctId":"NCT07319715","phase":"PHASE2","title":"Cerclage and Progesterone for Twin Pregnancies","status":"COMPLETED","sponsor":"Benha University","startDate":"2023-01-20","conditions":"Twin Pregnancy With Antenatal Problem","enrollment":59},{"nctId":"NCT05080569","phase":"PHASE4","title":"Luteal Phase Support in IUI MOH Treatment Luteal Phase Support in IUI MOH Treatment","status":"RECRUITING","sponsor":"UMC Utrecht","startDate":"2023-03-01","conditions":"Pregnancy Related, Fertility Issues, Luteal Phase Defect","enrollment":1008},{"nctId":"NCT07307092","phase":"NA","title":"Intramuscular vs Rectal Progesterone in Preventing Preterm Labour After Cervical Cerclage","status":"COMPLETED","sponsor":"Hina Mukhtar","startDate":"2021-10-26","conditions":"Preterm Labour, Cervical Insufficiency, Pregnancy, High-Risk","enrollment":820},{"nctId":"NCT06807580","phase":"PHASE2","title":"Progesterone in Gender Affirming Hormone Therapy Study","status":"RECRUITING","sponsor":"Emory University","startDate":"2025-05-12","conditions":"Transgender Women","enrollment":40},{"nctId":"NCT04112368","phase":"PHASE4","title":"Cyclical Neuroactive Steroid Changes, Arousal, and Proximal Suicide Risk: An Experimental Approach","status":"COMPLETED","sponsor":"University of Illinois at Chicago","startDate":"2020-09-15","conditions":"Suicidal Ideation","enrollment":124},{"nctId":"NCT05555121","phase":"PHASE2","title":"Rescue Progesterone Supplementation During Frozen Embryo Transfer","status":"SUSPENDED","sponsor":"Clinique Ovo","startDate":"2022-12-01","conditions":"Fertility Issues, Embryo Implantation, Frozen Embryo Transfer","enrollment":150},{"nctId":"NCT05388656","phase":"PHASE4","title":"Estrogen Variability and Irritability During the Menopause Transition","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-06-15","conditions":"Menopause, Irritable Mood","enrollment":40},{"nctId":"NCT05704036","phase":"PHASE4","title":"Estrogen Supplementation and Bone Health in Women With CF","status":"RECRUITING","sponsor":"Johns Hopkins University","startDate":"2023-05-02","conditions":"Cystic Fibrosis, Hypoestrogenism","enrollment":75},{"nctId":"NCT06372119","phase":"NA","title":"Letrozole-stimulated Cycle Strategy Versus Artificial Cycle Strategy (LETSACT)","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-04-22","conditions":"Embryo Transfer, Irregular Menstruation, Letrozole","enrollment":790},{"nctId":"NCT07173361","phase":"PHASE1","title":"Progesterone and Muscle Protein Synthesis in Premenopausal Women (MP4-MPS)","status":"NOT_YET_RECRUITING","sponsor":"McMaster University","startDate":"2025-09-15","conditions":"Healthy Volunteers, Female, Progesterone","enrollment":20},{"nctId":"NCT06463652","phase":"NA","title":"Cerclage With Progesterone Versus Progesterone Only in Singleton Pregnancies","status":"RECRUITING","sponsor":"Mỹ Đức Hospital","startDate":"2024-06-26","conditions":"Preterm Birth, Short Cervix","enrollment":328},{"nctId":"NCT06668896","phase":"PHASE1","title":"Comparing the Pharmacokinetics of a Progesterone Ring Versus a Progesterone Vaginal Insert","status":"NOT_YET_RECRUITING","sponsor":"Daré Bioscience, Inc.","startDate":"2025-11","conditions":"Pre Term Birth","enrollment":60},{"nctId":"NCT07020429","phase":"NA","title":"Efficacy and Safety of Huanjingjian Decoction in Women With Premature Ovarian Insufficiency","status":"NOT_YET_RECRUITING","sponsor":"Shanghai Pulmonary Hospital, Shanghai, China","startDate":"2025-09-01","conditions":"Premature Ovarian Insufficiency","enrollment":276},{"nctId":"NCT06834594","phase":"PHASE4","title":"Bleeding Patterns in Sequential and Continuous Progesterone Supplementation in Adolescents With Turner Syndrome","status":"RECRUITING","sponsor":"Children's Mercy Hospital Kansas City","startDate":"2025-07-31","conditions":"Turner Syndrome, Primary Ovarian Insufficiency (Poi)","enrollment":40},{"nctId":"NCT06306404","phase":"PHASE4","title":"Sleeping Through Menopause","status":"NOT_YET_RECRUITING","sponsor":"VU University of Amsterdam","startDate":"2025-10-01","conditions":"Menopause, Insomnia","enrollment":222},{"nctId":"NCT03068910","phase":"EARLY_PHASE1","title":"Hyperandrogenemia and Altered Day-night LH Pulse Patterns","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2016-07-21","conditions":"Hyperandrogenism, Polycystic Ovary Syndrome, Puberty","enrollment":32},{"nctId":"NCT00929006","phase":"EARLY_PHASE1","title":"Acute Progesterone Suppression of Wake vs. Sleep Luteinizing Hormone Pulse Frequency in Pubertal Girls With and Without Hyperandrogenism","status":"RECRUITING","sponsor":"University of Virginia","startDate":"2008-06","conditions":"Puberty, Hyperandrogenism","enrollment":36},{"nctId":"NCT04833140","phase":"PHASE3","title":"Estrogen Administration for the Treatment of NASH in Postmenopausal Women","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-12-02","conditions":"NASH - Nonalcoholic Steatohepatitis","enrollment":60},{"nctId":"NCT06875752","phase":"PHASE4","title":"Is There a Need for Luteal Support in Modified Natural Cycle Frozen Embryo Transfer Cycles","status":"RECRUITING","sponsor":"Dunamenti REK Istenhegyi IVF Center","startDate":"2025-04-12","conditions":"Luteal Support, Frozen Embryo Transfer (FET)","enrollment":180},{"nctId":"NCT06856174","phase":"PHASE4","title":"Menopausal HT for Women Living With HIV (HoT)","status":"NOT_YET_RECRUITING","sponsor":"Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections","startDate":"2026-01-19","conditions":"HIV Infection, Menopause","enrollment":105},{"nctId":"NCT03507673","phase":"","title":"Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phase in Assisted Reproduction","status":"RECRUITING","sponsor":"University of Luebeck","startDate":"2018-05-02","conditions":"Infertility","enrollment":1200},{"nctId":"NCT06975943","phase":"NA","title":"Comparison in Cervical Length and Prolongation of Gestation Age on Vaginal Progesterone Administration to Pregnant Women After the Acute Phase of Threatened Preterm Birth","status":"ACTIVE_NOT_RECRUITING","sponsor":"Dr. Soetomo General Hospital","startDate":"2024-01-01","conditions":"Pregnant Women, Pregnancies at Increased Risk of Preterm Birth","enrollment":48},{"nctId":"NCT03740204","phase":"PHASE2","title":"The Role of Estrogen in the Neurobiology of Eating Disorders","status":"RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2019-06-13","conditions":"Eating Disorders, Hypoestrogenemia","enrollment":120},{"nctId":"NCT00594217","phase":"PHASE1","title":"Determining How Quickly Progesterone Slows LH Pulse Frequency","status":"COMPLETED","sponsor":"University of Virginia","startDate":"2007-11-29","conditions":"Normal, PCOS","enrollment":85},{"nctId":"NCT03018366","phase":"PHASE2","title":"Atherosclerosis, Immune Mediated Inflammation and Hypoestrogenemia in Young Women","status":"COMPLETED","sponsor":"Cedars-Sinai Medical Center","startDate":"2017-01-01","conditions":"Estrogen Deficiency, Cardiovascular Disease (CVD), Functional Hypothalamic Amenorrhea","enrollment":29},{"nctId":"NCT06870266","phase":"EARLY_PHASE1","title":"Comparison of Pregnancy Rates in Modified Natural Frozen Embryo Transfer (FET) Cycle After Luteal Support with GnRH Agonist Versus Progesterone","status":"NOT_YET_RECRUITING","sponsor":"Shaare Zedek Medical Center","startDate":"2025-03","conditions":"Ivf, Frozen Embryo Transfer (FET)","enrollment":150},{"nctId":"NCT06715514","phase":"NA","title":"Menopausal Hormone Therapy, GLP-1 Agonists, and Glucose and Energy Homeostasis in Postmenopausal Women With Diabetes","status":"RECRUITING","sponsor":"Lia Bally","startDate":"2025-02-18","conditions":"Menopause, Type 2 Diabetes","enrollment":96},{"nctId":"NCT03642665","phase":"PHASE4","title":"Natural Versus Artificial Cycle for Frozen-Thawed Embryo Transfer","status":"COMPLETED","sponsor":"Universitaire Ziekenhuizen KU Leuven","startDate":"2018-09-25","conditions":"Embryo Transfer","enrollment":554},{"nctId":"NCT05282277","phase":"PHASE4","title":"Examining the Effects of Estradiol on Neural and Molecular Response to Reward","status":"RECRUITING","sponsor":"University of North Carolina, Chapel Hill","startDate":"2022-04-20","conditions":"Depression, Psychosis, Anhedonia","enrollment":103},{"nctId":"NCT06763926","phase":"PHASE4","title":"Intranasal Nafarelin For Triggering Oocyte Maturation","status":"NOT_YET_RECRUITING","sponsor":"Fundacion Dexeus","startDate":"2025-03-15","conditions":"Fertility Disorders","enrollment":134},{"nctId":"NCT05473273","phase":"","title":"Descriptive Analysis of Serum Immunological Markers During an Euploid Frozen Embryo Transfer in a Natural Cycle.","status":"RECRUITING","sponsor":"ART Fertility Clinics LLC","startDate":"2023-04-24","conditions":"Infertility, Female","enrollment":40},{"nctId":"NCT05903820","phase":"PHASE4","title":"Rhythmic Estradiol and Bone Health","status":"COMPLETED","sponsor":"Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)","startDate":"2023-07-19","conditions":"Osteoporosis Risk, Menopause","enrollment":48},{"nctId":"NCT05286554","phase":"PHASE4","title":"Addition of Gonadotropin Releasing Hormone Agonist to Luteal Phase Support","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-03-17","conditions":"Female Infertility","enrollment":75},{"nctId":"NCT03976544","phase":"PHASE4","title":"Natural Cycle Versus Hormone Replacement Therapy Cycle for a Frozen-thawed Embryo Transfer in PGT Patients","status":"TERMINATED","sponsor":"CRG UZ Brussel","startDate":"2019-05-25","conditions":"Miscarriage, Frozen Embryo Transfer, Natural Cycle","enrollment":362},{"nctId":"NCT04312399","phase":"NA","title":"Hormone Replacement Trial Against ALzheimers' Disease","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2018-04-17","conditions":"Postmenopausal Symptoms, Alzheimer Disease","enrollment":600},{"nctId":"NCT05601700","phase":"PHASE3","title":"Letrozole for Estrogen/Progesterone Receptor Positive Low-grade Serous Epithelial Ovarian Cancer (LEPRE Trial)","status":"RECRUITING","sponsor":"Ente Ospedaliero Ospedali Galliera","startDate":"2022-09-22","conditions":"Carcinoma, Ovarian Epithelial, Low Grade Serous Adenocarcinoma of Ovary","enrollment":132},{"nctId":"NCT04301518","phase":"NA","title":"Prematurity Risk Assessment Combined With Clinical Interventions for Improving Neonatal outcoMEs","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sera Prognostics, Inc.","startDate":"2020-11-06","conditions":"Preterm Labor, Preterm Birth","enrollment":6500},{"nctId":"NCT06357442","phase":"","title":"Assessment of Endometrial Thickness Among Adolescent and Young Adult Patients on Estrogen Replacement Therapy Using Daily Oral Micronized Progesterone Versus the Etonogestrel Implant.","status":"RECRUITING","sponsor":"University of Colorado, Denver","startDate":"2024-07-01","conditions":"Primary Ovarian Insufficiency, Hypogonadotropic Hypogonadism, Hormone Replacement Therapy","enrollment":34},{"nctId":"NCT06091436","phase":"PHASE3","title":"To Investigate Efficacy and Safety of a Single Injection of GenSci094 for Ovarian Stimulation Using Daily Recombinant FSH as Reference","status":"COMPLETED","sponsor":"Changchun GeneScience Pharmaceutical Co., Ltd.","startDate":"2023-03-24","conditions":"Infertility","enrollment":176},{"nctId":"NCT06644794","phase":"PHASE3","title":"Progesterone-modified Natural Cycle for FET","status":"NOT_YET_RECRUITING","sponsor":"Shandong University of Traditional Chinese Medicine","startDate":"2024-12-05","conditions":"Infertility, Female","enrollment":336},{"nctId":"NCT05418426","phase":"PHASE1","title":"A Phase 1, Open-Label, Parallel Group Study to Evaluate the Pharmacokinetics and Safety of DARE-HRT1 in Healthy PostMenopausal Women","status":"COMPLETED","sponsor":"Daré Bioscience, Inc.","startDate":"2020-08-18","conditions":"Vulvovaginal Atrophy, Vasomotor Symptoms","enrollment":34},{"nctId":"NCT01143064","phase":"PHASE3","title":"Efficacy and Safety Study of Intravenous Progesterone in Patients With Severe Traumatic Brain Injury","status":"COMPLETED","sponsor":"BHR Pharma, LLC","startDate":"2010-06","conditions":"Brain Injuries","enrollment":1195},{"nctId":"NCT06616077","phase":"EARLY_PHASE1","title":"Endometrial Transcript Profile with Progesterone After Post-ovulatory Mifepristone","status":"COMPLETED","sponsor":"Reproductive Health Research Insritute, Chile","startDate":"2022-06-07","conditions":"Endometrial Endocrine Regulation, Progesterone Supplementation in Women After Mifepristone","enrollment":9},{"nctId":"NCT00703014","phase":"","title":"Pregnancy and Neonatal Follow-up of Ongoing Pregnancies Established in Clinical Trial P05787 (P05712)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-07-13","conditions":"Pregnancy, Neonates","enrollment":541},{"nctId":"NCT00702273","phase":"","title":"Follow-up Study of Frozen-thawed Embryo Transfer (FTET) Cycles After Cryopreservation of Embryos in Clinical Trial P05787 (P05716)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-04-19","conditions":"In Vitro Fertilization","enrollment":344},{"nctId":"NCT06560814","phase":"PHASE2","title":"Non-surgical Interventions for Infertility in Endometriosis","status":"COMPLETED","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2020-07-01","conditions":"Endometriosis, Infertility, Female","enrollment":18},{"nctId":"NCT06530459","phase":"PHASE2, PHASE3","title":"The MUSE Study for Menopausal Arthralgia","status":"RECRUITING","sponsor":"National University Hospital, Singapore","startDate":"2024-08-01","conditions":"Arthralgia, Menopause, Perimenopausal Disorder","enrollment":100},{"nctId":"NCT04804020","phase":"NA","title":"Natural Cycle vs. Modified Natural Cycle vs. Artificial Cycle Protocol for Endometrial Preparation.","status":"COMPLETED","sponsor":"Mỹ Đức Hospital","startDate":"2021-03-22","conditions":"IVF, Frozen Embryo Transfer","enrollment":1428},{"nctId":"NCT05899010","phase":"PHASE3","title":"MIcronized PROgesterone in Frozen Embryo Transfer Cycles","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2023-07-05","conditions":"Infertility","enrollment":1020},{"nctId":"NCT00696800","phase":"PHASE3","title":"A Study to Investigate the Efficacy and Safety of a Single Injection of Corifollitropin Alfa (Organon 36286) for Ovarian Stimulation Using Daily Recombinant Follicle Stimulating Hormone (FSH) as Reference (P05787)","status":"COMPLETED","sponsor":"Organon and Co","startDate":"2006-06-27","conditions":"In Vitro Fertilization","enrollment":1509},{"nctId":"NCT04758871","phase":"PHASE4","title":"Oral Versus Vaginal Progesterone for Luteal Phase Supplementation in Frozen Embryo Transfer Cycles","status":"COMPLETED","sponsor":"CRG UZ Brussel","startDate":"2021-10-01","conditions":"Frozen Embryo Transfer, Hormone Replacement Therapy, Dydrogesterone","enrollment":150},{"nctId":"NCT05586724","phase":"PHASE3","title":"Micronized Progesterone Versus Norethisterone Acetate in Combination With Estrogen as Menopausal Hormone Therapy","status":"RECRUITING","sponsor":"Angelica Lindén Hirschberg","startDate":"2022-03-15","conditions":"Menopausal Symptoms","enrollment":520},{"nctId":"NCT02418572","phase":"PHASE3","title":"Testosterone TRANSdermal Gel for Poor Ovarian Responders Trial","status":"TERMINATED","sponsor":"Fundacion Dexeus","startDate":"2015-04","conditions":"Infertility, Poor Ovarian Response","enrollment":290},{"nctId":"NCT04719000","phase":"PHASE4","title":"PErsonalized Addition of Recombinant LH in Ovarian Stimulation","status":"RECRUITING","sponsor":"Fundación Santiago Dexeus Font","startDate":"2021-02-04","conditions":"Infertility","enrollment":120},{"nctId":"NCT05128071","phase":"EARLY_PHASE1","title":"PRevention Of Methamphetamine Use Among Postpartum Women Trial (PROMPT)","status":"RECRUITING","sponsor":"University of Utah","startDate":"2022-02-04","conditions":"Methamphetamine-dependence, Postpartum Abstinence","enrollment":40},{"nctId":"NCT04433897","phase":"","title":"Effect of Hormonal Replacement Therapy on Nocturia in Postmenopausal Women","status":"RECRUITING","sponsor":"University Hospital, Ghent","startDate":"2018-06-01","conditions":"Nocturia","enrollment":300},{"nctId":"NCT04092829","phase":"NA","title":"Impact of Corpus Luteum Presence or Absence in the Incidence of Preeclampsia After Frozen Embryo Transfer","status":"TERMINATED","sponsor":"Instituto Valenciano de Infertilidad, IVI VALENCIA","startDate":"2019-09-16","conditions":"Pre-Eclampsia, Frozen Embryo Transfer","enrollment":591},{"nctId":"NCT04534881","phase":"PHASE2","title":"Effect of Progesterone on Testosterone Concentrations and Breast Development in Transwomen","status":"TERMINATED","sponsor":"St. Louis University","startDate":"2020-10-20","conditions":"Transgender Persons","enrollment":5},{"nctId":"NCT03858049","phase":"PHASE4","title":"Efficacy and Safety of Crinone Versus Combination Medication (ACCESS)","status":"TERMINATED","sponsor":"Merck KGaA, Darmstadt, Germany","startDate":"2019-05-31","conditions":"Infertility","enrollment":172},{"nctId":"NCT06297564","phase":"NA","title":"Progesterone Primed Endometrial Protocol Versus Gonadotropin-releasing Hormone Antagonist Protocol in Assisted Reproductive Treatments","status":"COMPLETED","sponsor":"New Valley University","startDate":"2022-09-01","conditions":"Progesterone Primed Endometrial Protocol, Gonadotropin Releasing Hormone Antagonist Protocol, Assisted Reproductive Treatments","enrollment":40},{"nctId":"NCT03863613","phase":"NA","title":"Pessary Versus Cerclage With or Without Progesterone in Twins","status":"TERMINATED","sponsor":"Mỹ Đức Hospital","startDate":"2019-03-23","conditions":"Preterm Birth, Twin Pregnancy, Short Cervix","enrollment":219},{"nctId":"NCT04342585","phase":"PHASE3","title":"Comparison Between Vaginal Pessary and Progestogen in Twin Pregnancy With Short Cervical Length","status":"COMPLETED","sponsor":"National University of Malaysia","startDate":"2019-10-01","conditions":"Preterm Birth","enrollment":142},{"nctId":"NCT01589081","phase":"NA","title":"Effects of Progesterone on IV Nicotine-Induced Changes in Hormones and Subjective Ratings of Stimulant Drug Effect","status":"WITHDRAWN","sponsor":"Mclean Hospital","startDate":"2008-09","conditions":"Nicotine Dependence","enrollment":""},{"nctId":"NCT01589068","phase":"NA","title":"Effects of Progesterone on IV Nicotine Induced Changes on BOLD fMRI Signal, Hormones and Subjective Ratings of Stimulant Drugs","status":"WITHDRAWN","sponsor":"Mclean Hospital","startDate":"2007-01","conditions":"Nicotine Dependence","enrollment":""},{"nctId":"NCT04897269","phase":"PHASE3","title":"Progesterone Supplementation on Women Having Low Progesterone Levels on Transfer Day","status":"UNKNOWN","sponsor":"Tu Du Hospital","startDate":"2021-05-20","conditions":"Assisted Reproductive Technology","enrollment":824},{"nctId":"NCT03906669","phase":"PHASE2","title":"A Window of Opportunity Study of Pre-operative Endocrine Therapy With and Without Prometrium in Postmenopausal Women With Early Stage Breast Hormone Receptor Positive (HR+) Human Epidermal Receptor 2 Negative (HER2-) Breast Cancer.","status":"UNKNOWN","sponsor":"St Vincent's Hospital","startDate":"2018-03-20","conditions":"Early-stage Breast Cancer, Hormone Receptor Positive Tumor","enrollment":200},{"nctId":"NCT03637062","phase":"NA","title":"Verify the Safety and Effectiveness of the Cerclage Pessary in Prevention and Treatment of High-risk Preterm Pregnancy","status":"NOT_YET_RECRUITING","sponsor":"QH Medical Technology Ltd.","startDate":"2024-12-01","conditions":"High Risk Pregnancy","enrollment":300},{"nctId":"NCT04597099","phase":"EARLY_PHASE1","title":"Androgen Blockade and Progesterone Augmentation of Gonadotropin Secretion","status":"UNKNOWN","sponsor":"University of Virginia","startDate":"2022-10-26","conditions":"PCOS, Polycystic Ovary Syndrome","enrollment":10},{"nctId":"NCT01425541","phase":"NA","title":"Assessment of the Sensitivity of the Hypothalamic GnRH Pulse Generator to Estradiol and Progesterone Inhibition","status":"UNKNOWN","sponsor":"University of Virginia","startDate":"2000-04","conditions":"Hyperandrogenemia, Polycystic Ovary Syndrome (PCOS)","enrollment":60},{"nctId":"NCT03729869","phase":"PHASE2","title":"Impact of Progesterone on Stress Reactivity and Cannabis Use","status":"COMPLETED","sponsor":"Medical University of South Carolina","startDate":"2019-01-18","conditions":"Cannabis Use","enrollment":148},{"nctId":"NCT05997563","phase":"PHASE4","title":"Adjunctive Vaginal Progesterone in Management of Preterm Labor","status":"UNKNOWN","sponsor":"Chulalongkorn University","startDate":"2023-08-16","conditions":"Preterm Labor","enrollment":48},{"nctId":"NCT04051320","phase":"PHASE2","title":"Characterizing the Neural Substrates of Irritability in Women: an Experimental Neuroendocrine Model","status":"COMPLETED","sponsor":"University of North Carolina, Chapel Hill","startDate":"2020-01-02","conditions":"Perinatal Depression, Post Partum Depression, Depression, Postpartum","enrollment":23},{"nctId":"NCT02133573","phase":"PHASE2","title":"Randomized Trial of Maternal Progesterone Therapy","status":"COMPLETED","sponsor":"Children's Hospital of Philadelphia","startDate":"2014-07","conditions":"Congenital Heart Disease, Periventricular Leucomalacia, Brain Development","enrollment":102},{"nctId":"NCT04992468","phase":"PHASE4","title":"Dual Trigger for Elective Fertility Preservation","status":"COMPLETED","sponsor":"Fundación Santiago Dexeus Font","startDate":"2021-10-05","conditions":"Infertility","enrollment":136},{"nctId":"NCT03619707","phase":"PHASE4","title":"Oral Versus Vaginal Progesterone in the Luteal Support in Cryo-warmed Embryo Transfer Cycles","status":"COMPLETED","sponsor":"American University of Beirut Medical Center","startDate":"2018-08-01","conditions":"Sterility, Infertility","enrollment":157},{"nctId":"NCT04865029","phase":"PHASE2","title":"Estradiol and Progesterone in Hospitalized COVID-19 Patients","status":"TERMINATED","sponsor":"Tulane University","startDate":"2021-07-22","conditions":"Covid19","enrollment":10},{"nctId":"NCT05678192","phase":"PHASE1","title":"Effect of Menopausal Hormone Therapy on Immune System Parameters","status":"COMPLETED","sponsor":"Federal State Budget Institution Research Center for Obstetrics, Gynecology and Perinatology Ministry of Healthcare","startDate":"2021-12-01","conditions":"Last Period Not Earlier Than 6 Months Ago","enrollment":40}],"_emaApprovals":[],"_faersSignals":[{"count":383,"reaction":"EXPOSURE DURING PREGNANCY"},{"count":370,"reaction":"OFF LABEL USE"},{"count":346,"reaction":"HEADACHE"},{"count":321,"reaction":"PRODUCT USE ISSUE"},{"count":319,"reaction":"HYPERHIDROSIS"},{"count":318,"reaction":"HEPATIC ENZYME INCREASED"},{"count":317,"reaction":"IMMUNODEFICIENCY"},{"count":314,"reaction":"FOOD ALLERGY"},{"count":314,"reaction":"HYPERSENSITIVITY"},{"count":312,"reaction":"PAIN"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"chemblId":"CHEMBL103"},"formularyStatus":[],"_approvalHistory":[{"date":"20130821","type":"SUPPL","sponsor":"ABBVIE","applicationNumber":"NDA020701"},{"date":"20150929","type":"SUPPL","sponsor":"ABBVIE","applicationNumber":"NDA020701"},{"date":"20050323","type":"SUPPL","sponsor":"ABBVIE","applicationNumber":"NDA020701"},{"date":"20010420","type":"SUPPL","sponsor":"ABBVIE","applicationNumber":"NDA020701"},{"date":"20111208","type":"SUPPL","sponsor":"ABBVIE","applicationNumber":"NDA020701"},{"date":"20031112","type":"SUPPL","sponsor":"ABBVIE","applicationNumber":"NDA020701"},{"date":"20010403","type":"SUPPL","sponsor":"ABBVIE","applicationNumber":"NDA020701"},{"date":"19980511","type":"SUPPL","sponsor":"ABBVIE","applicationNumber":"NDA020701"},{"date":"19980217","type":"SUPPL","sponsor":"ABBVIE","applicationNumber":"NDA020701"},{"date":"20140304","type":"SUPPL","sponsor":"ABBVIE","applicationNumber":"NDA020701"},{"date":"20111208","type":"SUPPL","sponsor":"ABBVIE","applicationNumber":"NDA020701"},{"date":"20111208","type":"SUPPL","sponsor":"ABBVIE","applicationNumber":"NDA020701"},{"date":"20030917","type":"SUPPL","sponsor":"ABBVIE","applicationNumber":"NDA020701"},{"date":"19981216","type":"SUPPL","sponsor":"ABBVIE","applicationNumber":"NDA020701"},{"date":"19971211","type":"SUPPL","sponsor":"ABBVIE","applicationNumber":"NDA020701"},{"date":"19970731","type":"ORIG","sponsor":"ABBVIE","applicationNumber":"NDA020701"}],"developmentCodes":[],"ownershipHistory":[],"publicationCount":86,"therapeuticAreas":["Other"],"biosimilarFilings":[],"companionDiagnostics":[],"genericManufacturerList":[],"phase":"marketed","status":"active","brandName":"Crinone","genericName":"Crinone","companyName":"Ferring Pharmaceuticals","companyId":"ferring-pharmaceuticals","modality":"Small molecule","firstApprovalDate":"","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":1,"withResults":1},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:19:55.556953+00:00","fieldsConflicting":0,"overallConfidence":0.95},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}